ArticleBioinformatics (Oxford, England)2026
AIDrugDesigner: a web server for drug-like molecules generation and optimization.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationDesigning molecules with predefined properties remains a critical yet challenging task in drug discovery. Recent advances in deep learning have demonstrated strong potential in accelerating the identification of novel compounds with desired properties and activities. However, the implementation and running of these models often present difficulties due to varying environments and the requisite for additional coding competencies.
resultsHere, we present AIDrugDesigner, an integrated web server for practical deep learning-driven drug design. The platform consists of two modules: generation and optimization. The generation module supports target-aware drug design, pharmacophore-guided, property-conditioned, and linker design from diverse inputs. The optimization module refines user-provided molecules with respect to drug-likeness, LogP, and synthetic accessibility. By integrating multiple generative strategies into a unified interface, AIDrugDesigner reduces the technical barrier for applying deep learning models in drug discovery. Systematic evaluations across multiple design tasks further demonstrate its versatility. AVAILABILITY AND IMPLEMENTATION: The server is freely available at https://www.csuligroup.com/AIDrugDesigner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.